The authors suggested that the downregulation of RIPK1 expression promoted by epigenetic changes during tumor progression enables tumor cells to evade anoikis, which may stimulate tumorigenesis by enhancing the metastatic abilities of the tumor cells [9]. The gene discussed is RIPK1; the disease is neoplasm.